Germany discourages use of AstraZeneca vaccine for over 65s

 

The German Vaccine Board said in a draft recommendation that AstraZeneca’s COVID-19 vaccine should only be provided to people between 18 and 64 years old, one day before European regulators decide whether to approve the drug manufacturer’s injection. 

 



The committee said in a draft resolution provided by the German Ministry of Health on Thursday: “There is currently not enough data to evaluate the efficacy of vaccines over 65.” 

 


It added: “Unlike mRNA vaccines, AstraZeneca vaccines should only be provided to people aged 18-64 at each stage.” Stiko’s assessment is based on the same trial data published in the medical journal The Lancet on December 8.

Covid-19 Portugal Social issues

Covid: Portugal has 90.3 cases per 100K inhabitants

  According to a joint announcement by the General Administration of Health (DGS) and INSA, Portugal has 90.3 SARS-CoV-2 cases per 100,000 inhabitants, and its transmission index (Rt) is 0.84.    As stated by official data, the incidence rate was 79.1 cases per 100,000 inhabitants, and the Rt was 0.80 when analyzed in mainland Portugal […]

Read More
COVID19 Europe Italy Social issues

Italy reaches highest COVID-19 levels in several months

  Covid-19 cases in Italy reached their highest level in several months this week due to manufacturing problems that caused vaccines to be shipped to Italy at a slower rate than expected, forcing certain areas to return to confinement to prevent the worst-hit countries in the world to break out again.  Italian officials blamed this […]

Read More
Austria COVID19 Politics Vienna

Vienna: Thousands protest against coronavirus restrictions

  The police said thousands of people took part in the latest protests against coronavirus restrictions in Vienna on Saturday and were arrested for violating the Public Order Act and Covid’s regulations.    Many protesters did not wear masks and did not observe social distancing when they reached the park through the center of the […]

Read More

Please disable your adblocker or whitelist this site!